Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study

June 12, 2023 updated by: Carlo Fabbri, Azienda Unità Sanitaria Locale della Romagna
Among advanced resection techniques, endoscopic full thickness resection (EFTR) allows closure and full-thickness resection by the use of the non-exposed full thickness resection device (FTRD). The study is a retrospective analysis of technical failure occurring during colorectal full-thickness resection. Full thickness resection is a safe and effective procedure for "difficult" colorectal lesions. However, technical failure can occur and to date there is no evidence about type and clinical consequences in this setting.

Study Overview

Detailed Description

The study is a multicentre retrospective study involving centres with experience in advanced colorectal resections.

Each centre is invited to submit information about the Centre and to report alle the consecutive cases corresponding to technical failure.

Study Type

Observational

Enrollment (Actual)

77

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Forlì-Cesena
      • Forlì, Forlì-Cesena, Italy
        • Ospedale Morgagni-Pierantoni

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing colorectal EFTR with occurrence of technical failure.

Description

Inclusion Criteria:

  • Consecutive colorectal EFTR procedures with technical failure by using OVESCO Full Thickness Resection Device

Exclusion Criteria:

  • EFTR performed by exposed techniques and/or devices different from FTRD
  • Patients not able to give informed consent for data collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Procedures corresponding to technical failure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Technical failure rate and classification
Time Frame: 2014 - 2022
2014 - 2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conservative Management of technical failure
Time Frame: 2014-2022
Performance of rescue endoscopic resection
2014-2022
Clinical success (R0 resection)
Time Frame: 2014-2022
2014-2022
Complication rate
Time Frame: 2014-2022
2014-2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2022

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

January 31, 2023

Study Registration Dates

First Submitted

March 24, 2023

First Submitted That Met QC Criteria

June 12, 2023

First Posted (Actual)

June 22, 2023

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 12, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2993

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual Participant Data require data about experience in colorectal resections and EFTR; each centre will provide details for each technical failure including demographics, lesions characteristics, intraprocedural details and post-procedure outcomes.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Adenoma

Subscribe